Stuart Arbuckle
Chief Operating Officer chez VERTEX PHARMACEUTICALS INCORPORATED
Fortune : 21 M $ au 29/02/2024
Profil
M. Stuart A. Arbuckle est un administrateur indépendant de Rhythm Pharmaceuticals, Inc. et d'ImmunoGen, Inc. ainsi qu'un directeur de l'exploitation et un vice-président exécutif de Vertex Pharmaceuticals, Inc. Il siège au conseil d'administration de Rhythm Pharmaceuticals, Inc. et d'ImmunoGen, Inc. ainsi qu'à celui de la Biotechnology Innovation Organization et de la Cancer Support Community. Auparavant, M. Arbuckle a occupé le poste de vice-président et directeur général de l'unité commerciale d'oncologie chez Amgen, Inc. et celui de directeur chez GlaxoSmithKline Plc. Il a également siégé au conseil d'administration de Cerulean Pharma, Inc. et de Wellness Community. Il a obtenu son diplôme de premier cycle à l'université de Leeds.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
26/02/2024 | 49 831 ( 0,02% ) | 21 M $ | 29/02/2024 |
Postes actifs de Stuart Arbuckle
Sociétés | Poste | Début |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Chief Operating Officer | 01/02/2021 |
RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 24/07/2019 |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Director/Board Member | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Anciens postes connus de Stuart Arbuckle
Sociétés | Poste | Fin |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 12/02/2024 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Director/Board Member | 01/07/2017 |
AMGEN INC. | Corporate Officer/Principal | 01/08/2012 |
GSK PLC | Corporate Officer/Principal | - |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Director/Board Member | - |
Formation de Stuart Arbuckle
University of Leeds | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
AMGEN INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
Entreprise privées | 4 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Commercial Services |